Responses
Economic analysis
Cost-effectiveness study
Potential cost-savings may be considerable with management of hypertension according to updated US hypertension guidelines, but for women aged 35–44 years these benefits are unlikely
Compose a Response to This Article
Other responses
No responses have been published for this article.